Synthetic Sciences Raises $20M Backed by YC and a16z to Build AI Co-Scientists for Automated Research

Synthetic Sciences, a San Francisco–based AI research infrastructure startup building “AI co-scientists” that can autonomously run end-to-end scientific workflows, has raised early venture funding as it accelerates development of its platform for automating discovery in machine learning, biology, and computational science.

The company, founded in 2023 by Aayam Bansal and Ishaan Gangwani, is part of the growing wave of startups applying foundation models and agentic AI systems to scientific research. Its platform is designed to delegate the full research loop—literature review, hypothesis generation, experiment design, code execution, analysis, and paper writing—to AI systems that function as collaborative research agents. The goal is to compress research cycles that traditionally take weeks or months into continuous, automated iteration loops.

Synthetic Sciences has raised a total of approximately $20 million in funding, according to publicly available data, placing it among a well-capitalized cohort of early-stage “AI for science” startups. The company is currently operating at seed stage, with its most recent recorded financing round also classified as seed.

The startup’s investor base includes a mix of leading venture capital firms and high-profile angel and scout investors. Among the most notable institutional backers are Y Combinator, which provided early-stage accelerator funding and support, and Andreessen Horowitz, a major venture capital firm known for investing heavily in AI infrastructure and foundational model companies. Additional investors include Firestreak Ventures and Pareto Holdings, alongside individual angel investors and scout funds connected to the broader Silicon Valley ecosystem.

The company has also publicly stated backing from investors including Sequoia-affiliated scout networks and other early-stage science-focused capital groups, reflecting strong investor interest in the convergence of AI and scientific discovery platforms. This investor mix places Synthetic Sciences within a broader competitive landscape that includes AI research labs, biotech automation startups, and foundation model companies targeting domain-specific reasoning.

Synthetic Sciences’ platform is built around the idea that modern scientific research remains highly fragmented, requiring researchers to manually move between literature review tools, coding environments, compute infrastructure, and writing workflows. The company’s system aims to unify these steps into a single AI-driven loop where agents can maintain context across the entire research lifecycle and continuously improve experimental outcomes.

Early traction has been strongest in machine learning research environments, where the company reports its systems have already demonstrated strong performance on benchmarking tasks in biological modeling and computational reasoning. The startup is also expanding into adjacent domains such as protein modeling, systems biology, and materials science, where iterative experimentation and simulation play a central role.

The funding will be used to expand compute infrastructure, improve model training pipelines, and scale its “research agent” architecture, which combines large language models with tool-use capabilities such as code execution, containerized experimentation, and automated paper drafting. A key focus is improving the fidelity of scientific reasoning and reducing hallucination in multi-step experimental workflows.

With its $20 million in funding and backing from major investors including Y Combinator and Andreessen Horowitz, Synthetic Sciences is positioning itself in a rapidly expanding category of AI-native research infrastructure companies. These firms aim not merely to assist scientists, but to fundamentally re-architect how scientific discovery is conducted by automating the iterative loop between hypothesis, experiment, and publication.

As competition intensifies in the “AI for science” sector—alongside companies building automated labs, simulation engines, and domain-specific foundation models—Synthetic Sciences is betting that end-to-end autonomous research systems will become a core layer of future scientific productivity.

Share this:

Related Articles